[ORGANIZATION]
Ionis Pharmaceuticals
Featured in 11 tracked stories · first seen
Situations
FDA approval of Zanvastro for Alexander disease
2 clusters · 6 sources · last updated
Latest: FDA approves Zanvastro for Alexander disease treatment
The US Food and Drug Administration (FDA) has approved Zanvastro (zilganersen), developed by Ionis Pharmaceuticals, as the first disease-modifying treatment for Alexander disease (AxD). The therapy is indicated for both
Novartis CAR T cell therapy trial suspensions
2 clusters · 34 sources · last updated
Latest: Novartis shares plunge following dual clinical trial failures
Novartis has halted eight clinical trials involving an experimental CAR T cell therapy following three deaths. The fatalities were linked to immune effector cell-associated hemophagocytic syndrome (IEC-HS), a condition w
Lito Sousa transitions to home palliative care
10 clusters · 160 sources · last updated
Latest: Anvisa authorizes experimental drug for influencer Lito Sousa
Lito Sousa, a 59-year-old aviation specialist and creator of the YouTube channel ‘Aviões e Músicas’, continues to battle Creutzfeldt-Jakob disease (CJD), a rare and fatal neurodegenerative condition caused by infectious
Also covered in
-
Bepirovirsen shows promise in achieving functional cure for hepatitis B
[HEALTH] · 4 sources ·
-
Novartis and Ionis heart drug fails Phase III clinical trial
[BUSINESS] · 4 sources ·
-
Alnylam Pharmaceuticals cuts sales guidance amid Amvuttra performance issues
[BUSINESS] · 6 sources ·
-
Pharma Leaders Ipsen and Ionis Post Strong 2026 Earnings and Expansion Plans
[BUSINESS] · 4 sources ·